Novartis has made kidney disorders an area of focus, and it’s now adding a new drug prospect through a deal to acquire Regulus Therapeutics, a biotech with a drug ready for pivotal testing in a ...

Novartis NOVN1.25%increase; green up pointing triangle has agreed to acquire Regulus Therapeutics RGLS 0.25%increase; green up pointing triangle for a total equity value of up to roughly $1.7 ...

Novartis is set to buy U.S. biotech Regulus Therapeutics for up to $1.7 billion in a move to boost its renal-disease pipeline. The Swiss pharma giant said Wednesday that it would pay Regulus ...

Novartis AG agreed to buy US biotech Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 billion. The Swiss company will pay $7 a share in cash upfront through a subsidiary ...

(RTTNews) - Regulus Therapeutics (RGLS) has entered into an agreement and plan of merger with Novartis AG and an indirectly wholly owned subsidiary of Novartis, pursuant to which Novartis will ...

Novartis (NYSE:NVS) has agreed to acquire biopharmaceutical firm Regulus Therapeutics (NASDAQ:RGLS) for an initial payment of $7.00 a share in cash at closing, or $0.8B. The upfront cash portion ...

You can reach Jason on Signal at JasonMast.05. Novartis said Wednesday it would buy Regulus Therapeutics and its experimental kidney drug for $800 million upfront. The immediate payout is more ...

Swiss drug firm Novartis reported on Tuesday that it had generated a better-than-expected profit in the first three months of the year. Net sales were up 15% on a constant currency basis to $13.2 ...

Novartis AG, a pharmaceutical powerhouse with a market capitalization of $214.57 billion, reported robust financial results for the first quarter of 2025, with net sales growing by 15% in constant ...

Novartis NOVN1.90%increase; green up pointing triangle raised its 2025 outlook after high demand for key drugs drove first-quarter profit and sales above expectations, becoming the first among ...

Novartis has done a little spring cleaning, sweeping a phase 2 osteoarthritis prospect and first-in-human radioconjugate out of its pipeline after assessing evidence on the programs. The actions ...

BASEL, Switzerland (AP) — BASEL, Switzerland (AP) — Novartis AG (NVS) on Tuesday reported first-quarter net income of $3.61 billion. On a per-share basis, the Basel, Switzerland-based company ...